Edwards Lifesciences Corporation (ETR:EWL)
Germany · Delayed Price · Currency is EUR 63.79
-1.24 (-1.91%)
At close: Oct 10, 2025
Edwards Lifesciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| 5,685 | 5,440 | 5,010 | 4,464 | 5,233 | 4,386 | Upgrade | |
Revenue Growth (YoY) | 9.14% | 8.57% | 12.23% | -14.69% | 19.29% | 0.88% | Upgrade |
Cost of Revenue | 1,201 | 1,118 | 978.4 | 723.7 | 1,249 | 1,081 | Upgrade |
Gross Profit | 4,484 | 4,322 | 4,032 | 3,740 | 3,984 | 3,306 | Upgrade |
Selling, General & Admin | 1,881 | 1,789 | 1,583 | 1,358 | 1,494 | 1,228 | Upgrade |
Research & Development | 1,055 | 1,053 | 962.9 | 843.6 | 903.1 | 760.7 | Upgrade |
Other Operating Expenses | 159.9 | 101.7 | 177.3 | 40.7 | -103.5 | 419 | Upgrade |
Operating Income | 1,388 | 1,378 | 1,309 | 1,498 | 1,690 | 897.6 | Upgrade |
Interest Income | - | 120.3 | 67.2 | 35.5 | 17.4 | 23.4 | Upgrade |
Interest Expense | - | -19.8 | -17.6 | -19.2 | -18.4 | -15.8 | Upgrade |
Other Non-Operating Income (Expense) | 62.5 | 68.9 | 13.9 | 4.8 | 12.7 | 11.5 | Upgrade |
Total Non-Operating Income (Expense) | 62.5 | 169.4 | 63.5 | 21.1 | 11.7 | 19.1 | Upgrade |
Pretax Income | 1,450 | 1,548 | 1,372 | 1,520 | 1,702 | 916.7 | Upgrade |
Provision for Income Taxes | 220.4 | 152.1 | 152.4 | 195.5 | 198.9 | 93.3 | Upgrade |
Net Income | 4,148 | 4,175 | 1,402 | 1,522 | 1,503 | 823.4 | Upgrade |
Minority Interest in Earnings | -6 | -4.9 | -3 | - | - | - | Upgrade |
Earnings From Discontinued Operations | 2,735 | 2,774 | 179.4 | 197.9 | - | - | Upgrade |
Net Income to Common | 4,148 | 4,175 | 1,402 | 1,522 | 1,503 | 823.4 | Upgrade |
Net Income Growth | 181.57% | 197.68% | -7.85% | 1.25% | 82.55% | -21.35% | Upgrade |
Shares Outstanding (Basic) | 590 | 598 | 607 | 619 | 623 | 623 | Upgrade |
Shares Outstanding (Diluted) | 591 | 599 | 609 | 624 | 631 | 632 | Upgrade |
Shares Change (YoY) | -2.50% | -1.66% | -2.37% | -1.11% | -0.11% | -0.75% | Upgrade |
EPS (Basic) | 6.99 | 6.98 | 2.31 | 2.46 | 2.41 | 1.32 | Upgrade |
EPS (Diluted) | 6.98 | 6.97 | 2.30 | 2.44 | 2.38 | 1.30 | Upgrade |
EPS Growth | 187.24% | 203.04% | -5.74% | 2.52% | 83.08% | -20.73% | Upgrade |
Free Cash Flow | 587.9 | 289.9 | 642.8 | 973.6 | 1,406 | 647.3 | Upgrade |
Free Cash Flow Growth | 102.79% | -54.90% | -33.98% | -30.77% | 117.26% | -30.29% | Upgrade |
Free Cash Flow Per Share | 0.99 | 0.48 | 1.05 | 1.56 | 2.23 | 1.02 | Upgrade |
Gross Margin | 78.87% | 79.46% | 80.47% | 83.79% | 76.13% | 75.36% | Upgrade |
Operating Margin | 24.41% | 25.34% | 26.13% | 33.57% | 32.30% | 20.46% | Upgrade |
Profit Margin | 21.63% | 25.65% | 24.35% | 29.66% | 28.73% | 18.77% | Upgrade |
FCF Margin | 10.34% | 5.33% | 12.83% | 21.81% | 26.88% | 14.76% | Upgrade |
EBITDA | 1,540 | 1,533 | 1,454 | 1,638 | 1,825 | 1,005 | Upgrade |
EBITDA Margin | 27.08% | 28.19% | 29.02% | 36.69% | 34.88% | 22.91% | Upgrade |
EBIT | 1,388 | 1,378 | 1,309 | 1,498 | 1,690 | 897.6 | Upgrade |
EBIT Margin | 24.41% | 25.34% | 26.13% | 33.57% | 32.30% | 20.46% | Upgrade |
Effective Tax Rate | 15.20% | 9.83% | 11.10% | 12.87% | 11.69% | 10.18% | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.